Preoperative treatment of Hepatitis C is associated with lower prosthetic joint infection rates in US Veterans

Journal of Arthroplasty Mar 15, 2019

Bendich I, et al. – Via retrospective analysis of 2014-2018 data (n=42,628) from the US Department of Veterans Affairs, investigators assessed whether hepatitis C virus (HCV) is a modifiable risk factor in total joint arthroplasty (TJA) by comparing postoperative complications among patients with and without preoperative HCV treatment. They also determined lower prosthetic joint infection rates among US veterans. The investigators found that 6.0% of TJA patients had HCV, of whom 17.3% had received HCV treatment preoperatively. They noted lower implant infection rates at 90-days and 1-year postoperatively among treated HCV candidates vs untreated individuals. Among HCV-treated patients, odds ratios favored lower infection rates. They found lower rates of pneumonia and urinary tract infection in treated patients.

Go to Original
Non loggedin lock

To read this article Sign up / Login for free

This article is only available to members. Are you a doctor? Click here to signup for free.
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen